Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice

• Main Authors: Xiaotong Song (Author), Luchang Cao (Author), Baoyi Ni (Author), Jia Wang (Author), Xiaoyan Qin (Author), Xiaoyue Sun (Author), Bowen Xu (Author), Xinmiao Wang (Author), Jie Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic driver in non-small cell lung cancer (NSCLC). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are widely used in the treatment of lung cancer, especially in the first-line treatment of advanced NS...